This Medudy Expert Insight is a video tutorial for physicians on the topic of “Non-muscle-invasive bladder cancer – Perspectives on unmet medical needs.”
In this video, Prof. Dr. Axel Merseburger, Director of the Department of Urology at the University Medical Center Schleswig-Holstein, discusses key aspects of the unmet medical needs associated with non-muscle-invasive bladder cancer and current therapeutic prospects. The failure of current standard therapies, particularly in high-risk patients, leads to significant suffering among those affected. Despite the increasing availability of systemic and intravesical alternatives, there remains a high unmet medical need. In various studies and new treatment approaches, early-stage systemic therapies and immuno-oncology treatments show great potential as adjuncts to standard BCG therapy.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
This course was made possible with the generous support of AstraZeneca.
At the end of this training you will know:
- the significant unmet medical need in NMIBC
- The basics of classification and risk stratification of NMIBC
- the limitations of current standard therapy
- the potential of immuno-oncology as a complementary therapy
